Zaheer Yousef Selected Research

Zaheer Yousef Research Topics

13	Heart Failure 07/2021 - 01/2009
2	Type 2 Diabetes Mellitus (MODY) 02/2022 - 10/2019
2	Kidney Diseases (Kidney Disease) 01/2021 - 10/2019
1	Atrial Fibrillation 03/2024
1	Thrombosis (Thrombus) 12/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023
1	Cardiac Arrhythmias (Arrythmia) 03/2023
1	Apnea 03/2023
1	Chronic Disease (Chronic Diseases) 02/2022
1	Heart Arrest (Cardiac Arrest) 12/2021
1	Stroke (Strokes) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019
1	Neoplasms (Cancer) 03/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2011
1	Drug-Related Side Effects and Adverse Reactions 09/2009
1	Myocardial Infarction 09/2002

4	PerhexilineIBA 09/2016 - 09/2009
2	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2021 - 10/2019
1	CoagulantsIBA 12/2023
1	phosphatidylthreonineIBA 12/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2023
1	LipidsIBA 12/2023
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 03/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2022
1	semaglutideIBA 02/2022
1	1- ethyl- 4- phenyl- 1,2,3,6- tetrahydropyridineIBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	Sodium-Glucose Transporter 2IBA 10/2019
1	Metformin (Glucophage)FDA LinkGeneric 10/2019
1	AnthracyclinesIBA 03/2017
1	HematinicsIBA 01/2009
1	IronIBA 01/2009
1	Erythropoietin FDA Link 01/2009

8	Therapeutics 04/2021 - 09/2009
3	Cardiac Resynchronization Therapy 02/2021 - 12/2020
1	Wearable Electronic Devices 03/2024
1	Endurance Training 03/2023
1	Defibrillators (Defibrillator) 12/2021
1	Surgical Amputation (Amputations) 01/2021
1	Drug Therapy (Chemotherapy) 03/2017
1	Ligation 09/2002